Valbiotis obtains patent for its active substance TOTUM-63 in China.
Valbiotis has obtained a patent in China for TOTUM-63. This patent protects is issued by the China National Intellectual Property Administration (CNIPA), and protects the composition and use of TOTUM-63 for the prevention of type 2 diabetes and metabolic diseases until 2035.
Phone: +33 546 284 567
Contact: Marc Delaunay | firstname.lastname@example.org